Home › Companies › Abeona Therapeutics Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Abeona Therapeutics Inc.’s Form 8-K, filed June 12, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 12, 2026: 6 items on Abeona Therapeutics Inc.’s Form 8-K, filed June 12, 2026: 3 approved · 1 not approved · 2 without a stated outcome.
None beyond the items above.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2025-2026
Explore Abeona Therapeutics Inc. in the interactive database Compare manager voting policies
These tallies are Abeona Therapeutics Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Keith A. Goldan | 28,305,958 | 1,352,589 | 70,514 | -- | 12,256,230 | 95% | Not verified | — |
| Elect Director: Bernhardt G. Zeiher, M.D. | 28,131,990 | 1,577,444 | 19,627 | -- | 12,256,230 | 95% | Not verified | — |
| 2. Advisory Vote on Compensation of Named Executive Officers | 23,300,653 | 4,511,866 | 1,916,542 | -- | 12,256,230 | 84% | Approved | — |
| 3. Ratification of the Appointment of Deloitte & Touche LLP as our Independent Registered Public Accounting Firm | 40,560,995 | 1,381,486 | 42,810 | -- | -- | 97% | Approved | — |
| 4. Approval of an Increase in the Number of Shares Reserved for Issuance Under the Second A&R Plan | 23,975,061 | 5,720,643 | 33,357 | -- | 12,256,230 | 81% | Approved | — |
| 5. Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to remove the advance notice provision for director nominations | 24,559,006 | 4,667,640 | 502,415 | -- | 12,256,230 | 84% | Not approved Not approved under the vote the filing states was required: “66 2/3% of the outstanding” | a supermajority of the shares outstanding |
Source: Abeona Therapeutics Inc., Form 8-K, filed with the SEC on June 12, 2026 — read the filing on EDGAR.
Each item below shows how the 112 asset managers that disclosed a Abeona Therapeutics Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Abeona Therapeutics Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of three Class 1 Directors for a three-year term: Bernhardt G. Zeiher, M.D.
Abeona Therapeutics Inc.’s own tally for this item (“Elect Director: Bernhardt G. Zeiher, M.D.”): 28,131,990 for, 1,577,444 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 1,491,585 for, 1 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 563,506 | 1 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 500,342 | 0 | 0 | 0 | For |
| BlackRock | 129,498 | 0 | 0 | 0 | For |
| WisdomTree | 97,228 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 35,310 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,500 | 0 | 0 | 0 | For |
| Fidelity | 24,328 | 0 | 0 | 0 | For |
| Global X | 20,790 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,744 | 0 | 0 | 0 | For |
| Equitable | 10,984 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,480 | 0 | 0 | 0 | For |
| American Century | 7,538 | 0 | 0 | 0 | For |
| Charles Schwab | 6,346 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,314 | 0 | 0 | 0 | For |
| SEI | 4,700 | 0 | 0 | 0 | For |
| Calvert | 4,459 | 0 | 0 | 0 | For |
| John Hancock | 3,733 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 3,618 | 0 | 0 | 0 | For |
| Principal | 3,108 | 0 | 0 | 0 | For |
| Pacific Life | 3,102 | 0 | 0 | 0 | For |
| Voya | 2,554 | 0 | 0 | 0 | For |
| ProShares | 2,295 | 0 | 0 | 0 | For |
| State Street | 1,820 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,404 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of three Class 1 Directors for a three-year term: Keith A. Goldan
Abeona Therapeutics Inc.’s own tally for this item (“Elect Director: Keith A. Goldan”): 28,305,958 for, 1,352,589 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 1,491,585 for, 1 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 563,506 | 1 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 500,342 | 0 | 0 | 0 | For |
| BlackRock | 129,498 | 0 | 0 | 0 | For |
| WisdomTree | 97,228 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 35,310 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,500 | 0 | 0 | 0 | For |
| Fidelity | 24,328 | 0 | 0 | 0 | For |
| Global X | 20,790 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,744 | 0 | 0 | 0 | For |
| Equitable | 10,984 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,480 | 0 | 0 | 0 | For |
| American Century | 7,538 | 0 | 0 | 0 | For |
| Charles Schwab | 6,346 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,314 | 0 | 0 | 0 | For |
| SEI | 4,700 | 0 | 0 | 0 | For |
| Calvert | 4,459 | 0 | 0 | 0 | For |
| John Hancock | 3,733 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 3,618 | 0 | 0 | 0 | For |
| Principal | 3,108 | 0 | 0 | 0 | For |
| Pacific Life | 3,102 | 0 | 0 | 0 | For |
| Voya | 2,554 | 0 | 0 | 0 | For |
| ProShares | 2,295 | 0 | 0 | 0 | For |
| State Street | 1,820 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,404 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Combines 2 wordings of this item as funds reported it.
87% of fund votes cast · no official result
The 35 asset managers below reported 1,302,585 for, 189,001 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 563,063 | 444 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 500,342 | 0 | 0 | 0 | For |
| BlackRock | 0 | 129,498 | 0 | 0 | Against |
| WisdomTree | 97,228 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 35,310 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,500 | 0 | 0 | 0 | For |
| Fidelity | 11,782 | 12,546 | 0 | 0 | Mixed |
| Global X | 20,790 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,744 | 0 | 0 | 0 | For |
| Equitable | 0 | 10,984 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 8,480 | 0 | 0 | Against |
| American Century | 7,538 | 0 | 0 | 0 | For |
| Charles Schwab | 6,346 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 6,314 | 0 | 0 | Against |
| SEI | 4,700 | 0 | 0 | 0 | For |
| Calvert | 0 | 4,459 | 0 | 0 | Against |
| John Hancock | 0 | 3,733 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 3,618 | 0 | 0 | 0 | For |
| Principal | 0 | 3,108 | 0 | 0 | Against |
| Pacific Life | 0 | 3,102 | 0 | 0 | Against |
| Voya | 0 | 2,554 | 0 | 0 | Against |
| ProShares | 0 | 2,295 | 0 | 0 | Against |
| State Street | 1,820 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,404 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
84% Not approved · of votes cast
Description as filed by funds: To approve an amendment to the Company's Restated Certificate of Incorporation to remove the advance notice provision for director nominations.
Abeona Therapeutics Inc.’s own tally for this item (“5. Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to remove the advance notice provision for director nominations”): 24,559,006 for, 4,667,640 against — failed, per its Form 8-K filed June 12, 2026 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.
Reported outcome: Not approved, in the filing’s own words: “A proposal to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to remove the advance notice provision for director nominations was not approved because it did not receive the required affirmative vote of the holders of at least 66 2/3% of the outstanding share…”
Not approved under the vote the filing states was required: “66 2/3% of the outstanding”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Voting standard, as the filing states it: a supermajority of the shares outstanding (“66 2/3% of the outstanding”).
The 35 asset managers below reported 1,491,546 for, 40 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 563,467 | 40 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 500,342 | 0 | 0 | 0 | For |
| BlackRock | 129,498 | 0 | 0 | 0 | For |
| WisdomTree | 97,228 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 35,310 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,500 | 0 | 0 | 0 | For |
| Fidelity | 24,328 | 0 | 0 | 0 | For |
| Global X | 20,790 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,744 | 0 | 0 | 0 | For |
| Equitable | 10,984 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,480 | 0 | 0 | 0 | For |
| American Century | 7,538 | 0 | 0 | 0 | For |
| Charles Schwab | 6,346 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,314 | 0 | 0 | 0 | For |
| SEI | 4,700 | 0 | 0 | 0 | For |
| Calvert | 4,459 | 0 | 0 | 0 | For |
| John Hancock | 3,733 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 3,618 | 0 | 0 | 0 | For |
| Principal | 3,108 | 0 | 0 | 0 | For |
| Pacific Life | 3,102 | 0 | 0 | 0 | For |
| Voya | 2,554 | 0 | 0 | 0 | For |
| ProShares | 2,295 | 0 | 0 | 0 | For |
| State Street | 1,820 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,404 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
81% Approved · of votes cast
Description as filed by funds: To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000.
Abeona Therapeutics Inc.’s own tally for this item (“4. Approval of an Increase in the Number of Shares Reserved for Issuance Under the Second A&R Plan”): 23,975,061 for, 5,720,643 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “A proposal to an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000 was approved by the following votes:”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 563,467 | 40 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 500,342 | 0 | 0 | 0 | For |
| BlackRock | 129,498 | 0 | 0 | 0 | For |
| WisdomTree | 97,228 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 35,310 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,500 | 0 | 0 | 0 | For |
| Fidelity | 11,782 | 12,546 | 0 | 0 | Mixed |
| Global X | 20,790 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,744 | 0 | 0 | 0 | For |
| Equitable | 9,281 | 1,703 | 0 | 0 | Mixed |
| Bridge Builder Trust | 8,480 | 0 | 0 | 0 | For |
| American Century | 0 | 7,538 | 0 | 0 | Against |
| Charles Schwab | 6,346 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,314 | 0 | 0 | 0 | For |
| SEI | 4,700 | 0 | 0 | 0 | For |
| Calvert | 0 | 4,459 | 0 | 0 | Against |
| John Hancock | 3,733 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 3,618 | 0 | 0 | 0 | For |
| Principal | 3,108 | 0 | 0 | 0 | For |
| Pacific Life | 3,102 | 0 | 0 | 0 | For |
| Voya | 2,554 | 0 | 0 | 0 | For |
| ProShares | 2,295 | 0 | 0 | 0 | For |
| State Street | 1,820 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,404 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,400 | 0 | 0 | 0 | For |
Fund voting reports, all 35 managers: 1,465,300 for, 26,286 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rangeley Capital, LLC | 0 | 60,000 | 0 | 0 | Against |
Institutional-manager reports, all 1 managers: 60,000 against.
Combines 4 wordings of this item as funds reported it.
84% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers.
Abeona Therapeutics Inc.’s own tally for this item (“2. Advisory Vote on Compensation of Named Executive Officers”): 23,300,653 for, 4,511,866 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “An advisory vote to approve the compensation of the Company's named executive officers was approved by the following votes:”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 563,503 | 3 | 1 | 0 | For |
| Simplify Exchange Traded Funds | 500,342 | 0 | 0 | 0 | For |
| BlackRock | 129,498 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 97,228 | 0 | 0 | Against |
| Harbor ETF Trust | 35,310 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,500 | 0 | 0 | 0 | For |
| Fidelity | 24,328 | 0 | 0 | 0 | For |
| Global X | 20,790 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,744 | 0 | 0 | 0 | For |
| Equitable | 9,281 | 1,703 | 0 | 0 | Mixed |
| Bridge Builder Trust | 8,480 | 0 | 0 | 0 | For |
| American Century | 0 | 7,538 | 0 | 0 | Against |
| Charles Schwab | 6,346 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 6,314 | 0 | 0 | Against |
| SEI | 4,700 | 0 | 0 | 0 | For |
| Calvert | 0 | 4,459 | 0 | 0 | Against |
| John Hancock | 0 | 3,733 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 3,618 | 0 | 0 | 0 | For |
| Principal | 0 | 3,108 | 0 | 0 | Against |
| Pacific Life | 3,102 | 0 | 0 | 0 | For |
| Voya | 0 | 2,554 | 0 | 0 | Against |
| ProShares | 0 | 2,295 | 0 | 0 | Against |
| State Street | 1,820 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,404 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,400 | 0 | 0 | 0 | For |
Fund voting reports, all 35 managers: 1,361,946 for, 129,639 against, 1 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 4,385,779 | 0 | 0 | 0 | For |
| MONTANOVA CAPITAL, LLC | 2,553,916 | 0 | 0 | 0 | For |
| AIGH Capital Management LLC | 2,398,946 | 0 | 0 | 0 | For |
| NAN FUNG TRINITY (HK) Ltd | 0 | 956,770 | 0 | 0 | Against |
| AWM Investment Company, Inc. | 803,130 | 0 | 0 | 0 | For |
| Stonepine Capital Management, LLC | 746,587 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 0 | 467,379 | 0 | 0 | Against |
| State Street | 419,219 | 3,942 | 0 | 0 | For |
| J. Goldman & Co LP | 399,083 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 0 | 383,216 | 0 | 0 | Against |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 320,105 | 0 | 0 | Against |
| Northern Trust | 201,415 | 1,756 | 0 | 0 | For |
| BlackRock | 169,631 | 2,314 | 0 | 0 | For |
| DE Shaw | 0 | 99,083 | 0 | 0 | Against |
| BALYASNY ASSET MANAGEMENT L.P. | 94,085 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 69,316 | 0 | 0 | 0 | For |
| Rangeley Capital, LLC | 0 | 60,000 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 58,895 | 0 | 0 | Against |
| AQR | 0 | 45,891 | 0 | 0 | Against |
| Vanguard | 42,271 | 311 | 0 | 0 | For |
| PANAGORA ASSET MANAGEMENT INC | 0 | 25,826 | 0 | 0 | Against |
| Goldman Sachs | 21,825 | 0 | 0 | 0 | For |
| Invesco | 0 | 21,607 | 0 | 0 | Against |
| Citadel | 21,450 | 0 | 0 | 0 | For |
| Riverwater Partners LLC | 0 | 19,066 | 0 | 0 | Against |
Institutional-manager reports, all 89 managers: 12,468,021 for, 2,580,051 against. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: Ratify the appointment of Deloitte & Touche LLP as our independent registered public accountant for the fiscal year ending December 31, 2026.
Abeona Therapeutics Inc.’s own tally for this item (“3. Ratification of the Appointment of Deloitte & Touche LLP as our Independent Registered Public Accounting Firm”): 40,560,995 for, 1,381,486 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “A proposal to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026 was approved by the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 35 asset managers below reported 1,491,586 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 563,507 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 500,342 | 0 | 0 | 0 | For |
| BlackRock | 129,498 | 0 | 0 | 0 | For |
| WisdomTree | 97,228 | 0 | 0 | 0 | For |
| Harbor ETF Trust | 35,310 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,500 | 0 | 0 | 0 | For |
| Fidelity | 24,328 | 0 | 0 | 0 | For |
| Global X | 20,790 | 0 | 0 | 0 | For |
| Goldman Sachs | 17,744 | 0 | 0 | 0 | For |
| Equitable | 10,984 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 8,480 | 0 | 0 | 0 | For |
| American Century | 7,538 | 0 | 0 | 0 | For |
| Charles Schwab | 6,346 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 6,314 | 0 | 0 | 0 | For |
| SEI | 4,700 | 0 | 0 | 0 | For |
| Calvert | 4,459 | 0 | 0 | 0 | For |
| John Hancock | 3,733 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 3,618 | 0 | 0 | 0 | For |
| Principal | 3,108 | 0 | 0 | 0 | For |
| Pacific Life | 3,102 | 0 | 0 | 0 | For |
| Voya | 2,554 | 0 | 0 | 0 | For |
| ProShares | 2,295 | 0 | 0 | 0 | For |
| State Street | 1,820 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 1,404 | 0 | 0 | 0 | For |
| PENN SERIES FUNDS INC | 1,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 56,995,144 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 0.99% |
| 2 | Simplify Exchange Traded Funds | 0.88% |
| 3 | BlackRock | 0.23% |
| 4 | WisdomTree | 0.17% |
| 5 | Harbor ETF Trust | 0.06% |
| 6 | Lincoln Financial | 0.05% |
| 7 | Fidelity | 0.04% |
| 8 | Global X | 0.04% |
| 9 | Goldman Sachs | 0.03% |
| 10 | Equitable | 0.02% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Nantahala Capital Management, LLC | 7.70% |
| 2 | MONTANOVA CAPITAL, LLC | 4.48% |
| 3 | AIGH Capital Management LLC | 4.21% |
| 4 | NAN FUNG TRINITY (HK) Ltd | 1.68% |
| 5 | AWM Investment Company, Inc. | 1.41% |
| 6 | Stonepine Capital Management, LLC | 1.31% |
| 7 | KENNEDY CAPITAL MANAGEMENT LLC | 0.82% |
| 8 | State Street | 0.74% |
| 9 | J. Goldman & Co LP | 0.70% |
| 10 | 683 Capital Management, LLC | 0.67% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Nantahala Capital Management, LLC | 10.13% | 13G |
| NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 5.85% | 13G |
| BlackRock | 5.61% | 13F |
| Funicular Funds, LP | 5.28% | 13G |
| Daniel Kaufman | 5.16% | 13G |
| Vanguard Group | 4.84% | 13F |
| Vishwas Seshadri | 2.56% | DEF14A |
| Goldman Sachs | 1.98% | 13F |
| State Street | 1.68% | 13F |
| Joseph Vazzano | 1.00% | DEF14A |
Percentages above are of 56,995,144 shares outstanding, as reported by Abeona Therapeutics Inc. on its Form 10-Q dated May 8, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Abeona Therapeutics Inc.’s 10-Q dated May 8, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Abeona Therapeutics Inc.'s shareholder meeting held June 12, 2026, in the 2025-2026 proxy season, 112 asset managers reported how they voted in their SEC Form N-PX filings, covering 744 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers. — Abeona Therapeutics Inc.'s filing reports the proposal as approved, with 84% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Abeona Therapeutics Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2026.
Abeona Therapeutics Inc. proxy season coverage: 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.